Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study

Overview of attention for article published in Frontiers in immunology, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 27 Mendeley

Summary X Patents

So far, Altmetric has seen 1 X post from an account with 33,399 followers.

New Research: Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study: Background Interleukin-13 receptor α 2 (IL13Rα2) is a promising tumor-directed… https://t.co/B

08 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.